SynthesisBMJ (Clinical research ed.)2012

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

Thomas Karagiannis et al.PubMed ↗Publisher ↗

What the trial testedrandomised · 7,136 people · 2012

Randomised comparison

+0.20+0.08 to +0.32

As reported

difference 0.20, 95% CI 0.08–0.32

the abstract, start to end

… in HbA(1c) (weighted mean difference 0.20, 95% confidence interval 0.08 …

← favours treatmentfavours comparator →

could be chance

Body weight & composition

0.200.08–0.32

MetforminBody weight & composition

1 / 3

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

this paperpooled ittrialcites it